Sage Journals: Discover world-class research

Abstract

Objectives:

Waardenburg syndrome (WS) is a rare autosomal dominant disorder associated with pigmentation abnormalities and sensorineural hearing loss. In this study, we investigated the genetic cause of WSII in a patient and evaluated the reliability of the targeted next-generation exome sequencing method for the genetic diagnosis of WS.

Methods:

Clinical evaluations were conducted on the patient and targeted next-generation sequencing (NGS) was used to identify the candidate genes responsible for WSII. Multiplex ligation-dependent probe amplification (MLPA) and real-time quantitative polymerase chain reaction (qPCR) were performed to confirm the targeted NGS results.

Results:

Targeted NGS detected the entire deletion of the coding sequence (CDS) of the SOX10 gene in the WSII patient. MLPA results indicated that all exons of the SOX10 heterozygous deletion were detected; no aberrant copy number in the PAX3 and microphthalmia-associated transcription factor (MITF) genes was found. Real-time qPCR results identified the mutation as a de novo heterozygous deletion.

Conclusions:

This is the first report of using a targeted NGS method for WS candidate gene sequencing; its accuracy was verified by using the MLPA and qPCR methods. Our research provides a valuable method for the genetic diagnosis of WS.

Get full access to this article

View all access options for this article.

References

Antonellis

, Bennett

, Menheniott

, et al. (2006) Deletion of long-range sequences at Sox10 compromises developmental expression in a mouse model of Waardenburg-Shah (WS4) syndrome. Hum Mol Genet, 15:259-271.

Ashley

(2016) Towards precision medicine. Nat Rev Genet, 17:507-522.

Bondurand

, Dastot-Le Moal

, Stanchina

, et al. (2007) Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet, 81:1169-1185.

Bondurand

, Fouquet

, Baral

, et al. (2012) Alu-mediated deletion of SOX10 regulatory elements in Waardenburg syndrome type 4. Eur J Hum Genet, 20:990-994.

Chen

, Jiang

, Xie

, et al. (2010) Novel mutations of PAX3, MITF, and SOX10 genes in Chinese patients with type I or type II Waardenburg syndrome. Biochem Biophys Res Commun, 397:70-74.

Cortes-Gonzalez

, Zenteno

, Guzman-Sanchez

, et al. (2016) Tietz/Waardenburg type 2A syndrome associated with posterior microphthalmos in two unrelated patients with novel MITF gene mutations. Am J Med Genet A, 170:3294-3297.

Doubaj

, Pingault

, Elalaoui

, et al. (2015) A novel mutation in the endothelin B receptor gene in a moroccan family with Shah-Waardenburg syndrome. Mol Syndromol, 6:44-49.

Dourmishev

, Dourmishev

, Schwartz

, et al. (1999) Waardenburg syndrome. Int J Dermatol, 38:656-663.

Drozniewska

, Haus

(2014) PAX3 gene deletion detected by microarray analysis in a girl with hearing loss. Mol Cytogenet, 7:30.

10.

Falah

, Posey

, Thorson

, et al. (2017) 22q11.2q13 duplication including SOX10 causes sex-reversal and peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease. Am J Med Genet A, 173:1066-1070.

11.

Goldfeder

, Priest

, Zook

, et al. (2016) Medical implications of technical accuracy in genome sequencing. Genome Med, 8:24.

12.

Inoue

, Khajavi

, Ohyama

, et al. (2004) Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet, 36:361-369.

13.

Jelena

, Christina

, Eric

, et al. (2014) Phenotypic variability in Waardenburg syndrome resulting from a 22q12.3-q13.1 microdeletion involving SOX10. Am J Med Genet A, 164A:1512-1519.

14.

Kochhar

, Hildebrand

, Smith

(2007) Clinical aspects of hereditary hearing loss. Genet Med, 9:393-408.

15.

, Chen

, Fan

, et al. (2015) EPHA4 haploinsufficiency is responsible for the short stature of a patient with 2q35-q36.2 deletion and Waardenburg syndrome. BMC Med Genet, 16:23.

16.

Liu

, Newton

, Read

(1995) Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am J Med Genet, 55:95-100.

17.

Manning

, Hudgins

(2007) Use of array-based technology in the practice of medical genetics. Genet Med, 9:650-653.

18.

Morozova

, Marra

(2008) Applications of next-generation sequencing technologies in functional genomics. Genomics, 92:255-264.

19.

Sanchez-Martin

, Rodriguez-Garcia

, Perez-Losada

, et al. (2002) SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet, 11:3231-3236.

20.

Siomou

, Manolakos

, Petersen

, et al. (2012) A 725 kb deletion at 22q13.1 chromosomal region including SOX10 gene in a boy with a neurologic variant of Waardenburg syndrome type 2. Eur J Med Genet, 55:641-645.

21.

Tassabehji

, Newton

, Read

(1994) Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet, 8:251-255.

22.

Wenzhi

, Ruijin

, Jieliang

, et al. (2015) Heterozygous deletion at the SOX10 gene locus in two patients from a Chinese family with Waardenburg syndrome type II. Int J Pediatr Otorhinolaryngol, 79:1718-1721.

23.

Wildhardt

, Zirn

, Graul-Neumann

, et al. (2013) Spectrum of novel mutations found in Waardenburg syndrome types 1 and 2: implications for molecular genetic diagnostics. BMJ Open, 3:e001917.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.13 MB